DIGP Stock Overview
Digipath, Inc., together with its subsidiaries, developes cannabis and hemp.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Digipath, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.034 |
52 Week High | US$0.07 |
52 Week Low | US$0.0011 |
Beta | 0.74 |
1 Month Change | 100.88% |
3 Month Change | 58.84% |
1 Year Change | 367.81% |
3 Year Change | -11.76% |
5 Year Change | -82.03% |
Change since IPO | -99.66% |
Recent News & Updates
Recent updates
Shareholder Returns
DIGP | US Healthcare | US Market | |
---|---|---|---|
7D | 75.7% | 6.5% | -3.2% |
1Y | 367.8% | 4.0% | 19.3% |
Return vs Industry: DIGP exceeded the US Healthcare industry which returned 4% over the past year.
Return vs Market: DIGP exceeded the US Market which returned 19.3% over the past year.
Price Volatility
DIGP volatility | |
---|---|
DIGP Average Weekly Movement | 46.7% |
Healthcare Industry Average Movement | 6.9% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: DIGP's share price has been volatile over the past 3 months.
Volatility Over Time: DIGP's weekly volatility (47%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 17 | A. Douglass | digipath.com |
Digipath, Inc., together with its subsidiaries, developes cannabis and hemp. It provides testing, cannabis education and training, and cannabis news coverage to the cannabis industry. The company also operates as a testing laboratory facility for cannabis, cannabis infused products, hemp, and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients, and end users of cannabis and botanical products.
Digipath, Inc. Fundamentals Summary
DIGP fundamental statistics | |
---|---|
Market cap | US$3.60m |
Earnings (TTM) | -US$563.15k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-6.4x
P/E RatioIs DIGP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DIGP income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$563.15k |
Earnings | -US$563.15k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0053 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -136.8% |
How did DIGP perform over the long term?
See historical performance and comparison